Proton Pump Inhibitors, Histamine H2 Receptor Antagonists, and Other Antacid Medications and the Risk of Fracture

P Vestergaard, L Rejnmark, L Mosekilde - Calcified tissue international, 2006 - Springer
… We studied the effect of proton pump inhibitors, histamine H 2 receptor antagonists, and other
types of … The primary exposure variables were use of proton pump inhibitors, histamine H 2 …

Comparative effectiveness of proton pump inhibitors vs histamine type 2 receptor blockers for preventing clinically important gastrointestinal bleeding during intensive …

CM Lilly, M Aljawadi, O Badawi, E Onukwugha… - Chest, 2018 - Elsevier
Proton pump inhibitors (PPIs) and histamine type 2 receptor blockers (H2Bs) are used for
stress ulcer prophylaxis. Although the PPIs have greater potency for acid suppression, their …

[HTML][HTML] Impact of proton pump inhibitors and histamine-2-receptor antagonists on non-small cell lung cancer immunotherapy: a systematic review and meta-analysis

A Rizzo, A Cusmai, F Giovannelli, S Acquafredda… - Cancers, 2022 - mdpi.com
… The current meta-analysis highlighted that proton pump inhibitors (PPIs) and histamine-2-receptor
antagonists (H2RAs) could impact immune checkpoint inhibitors (ICIs) efficacy in …

Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis

W Alhazzani, F Alenezi, RZ Jaeschke… - Critical care …, 2013 - journals.lww.com
proton pump inhibitors are more effective than histamine 2 … Proton pump inhibitors were
more effective than histamine 2 … no differences between proton pump inhibitors and histamine 2 …

Proton pump inhibitors versus histamine-2 receptor antagonists and risk of pneumonia in patients with acute stroke

R Momosaki, H Yasunaga, H Matsui, K Fushimi… - Journal of Stroke and …, 2016 - Elsevier
… We performed propensity score-matched analysis to compare the outcome between
proton pump inhibitor (PPI) users and histamine-2 receptor antagonist (H2RA) users. …

Proton pump inhibitors and histamine-2 receptor antagonists on the risk of pancreatic cancer: a systematic review and meta-analysis

P Laoveeravat, S Thavaraputta… - … Journal of Medicine, 2020 - academic.oup.com
… We used search strategies consisting of the terms ‘PPI’ OR ‘histamine receptor blocker’ OR
histamine receptor antagonist’ AND ‘pancreatic cancer’ as shown in Supplementary Data S1…

Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency

JR Lam, JL Schneider, W Zhao, DA Corley - Jama, 2013 - jamanetwork.com
… Importance Proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H 2 RAs)
suppress the production of gastric acid and thus may lead to malabsorption of vitamin B 12 . …

Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit

R MacLaren, PM Reynolds, RR Allen - JAMA internal medicine, 2014 - jamanetwork.com
Proton pump inhibitor therapy is associated with greater risks of GI hemorrhage, pneumonia,
and CDI compared with H 2 RA therapy in mechanically ventilated patients. Numerous …

A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used …

C Boyd, T Hassig, R MacLaren - … : The Journal of Human …, 2021 - Wiley Online Library
… This study assessed the effectiveness and safety of proton pump inhibitors (PPIs) compared
to histamine type 2 receptor antagonists (H2RAs) for prevention of CIGB in mechanically …

Proton pump inhibitor use and fracture risk—effect modification by histamine H1 receptor blockade. Observational case–control study using National Prescription Data

B Abrahamsen, P Vestergaard - Bone, 2013 - Elsevier
… express histamine receptors. Moreover, the distribution of type 1 and type 2 histamine … [13],
and only blockade of the type 1 receptor appears effective in reducing bone resorption by the …